| Quest – Discovery Stage Research Projects | Ronald Mark Evans | Extending Immune-Evasive Human Islet-Like Organoids (HILOs) Survival and Function as a Cure for T1D |
$1,523,285 |
| Quest – Discovery Stage Research Projects | Ronald Mark Evans | Therapeutic immune tolerant human islet-like organoids (HILOs) for Type 1 Diabetes |
$1,637,209 |
| Preclinical Development Awards | Dr. David R Schubert | Human Stem-Cell Based Development of a Potent Alzheimer’s Drug Candidate |
$1,664,885 |
| Genomics Centers of Excellence Awards (R) | Dr. Joseph R Ecker | Center of Excellence for Stem Cell Genomics – Salk |
$13,201,635 |
| Disease Team Planning | Prof. Samuel Lawrence Pfaff | Motor neuron diseases: Finding cures through basic, translational, and clinical collaboration |
$51,266 |
| Basic Biology V | Ronald Mark Evans | Metabolically-driven epigenetic changes in iPSC reprogramming |
$1,491,900 |
| Early Translational IV | Dr. Inder M. Verma | Development of a cell and gene based therapy for hemophilia |
$2,298,634 |
| Early Translational III | Dr. David R Schubert | Stem cell based small molecule therapy for Alzheimer’s disease |
$1,673,757 |
| Early Translational III | Juan Carlos Izpisua Belmonte | Direct reprogramming towards vascular progenitors for the treatment of ischemia |
$2,340,000 |
| Training Grant I-3 | Juan Carlos Izpisua Belmonte | Training in the Biology of Human Enbryonic Stem Cells and Emerging Technologies |
$1,261,333 |
| Research Training II | Juan Carlos Izpisua Belmonte | Training in the Biology of Human Embryonic Stem Cells and Emerging Technologies II |
$2,886,221 |
| Early Translational II | Dr. Fred H Gage | Crosstalk: Inflammation in Parkinson’s disease (PD) in a humanized in vitro model |
$2,472,839 |
| New Faculty I | Dr. Dana Leanne Jones | Characterization of mechanisms regulating de-differentiation and the re-acquisition of stem cell identity |
$2,134,100 |
| New Faculty I | Dr. Lei Wang | Genetic Encoding Novel Amino Acids in Embryonic Stem Cells for Molecular Understanding of Differentiation to Dopamine Neurons |
$2,587,742 |
| Early Translational I | Dr. Inder M. Verma | Curing Hematological Diseases |
$5,979,252 |
| Shared Labs | Garry Van Gerpen | Shared viral vector facility for genetic manipulation of huamn ES cell |
$1,478,923 |
| Shared Labs | Dr. Inder M. Verma | Shared viral vector facility for genetic manipulation of huamn ES cell |
$1,844,315 |
| New Cell Lines | Dr. Fred H Gage | Development of Induced Pluripotent Stem Cells for Modeling Human Disease |
$1,737,720 |
| Comprehensive Grant | Dr. Fred H Gage | Molecular and Cellular Transitions from ES Cells to Mature Functioning Human Neurons |
$2,749,293 |
| SEED Grant | Prof. Samuel Lawrence Pfaff | Gene regulatory mechanisms that control spinal neuron differentiation from hES cells. |
$704,543 |
| SEED Grant | Dr. Senyon Choe | A method to maintain and propagate pluripotent human ES cells |
$760,042 |
| SEED Grant | Dr. Beverly M Emerson Dr. | Regulation of Specific Chromosomal Boundary Elements by CTCF Protein Complexes in Human Embryonic Stem Cells |
$647,343 |
| Basic Biology II | Ronald Mark Evans | Molecular Characterization and Functional Exploration of Nuclear Receptors in hiPSCs |
$1,712,880 |
